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PRELIMINARY REPORT
THE INHIBITION OF ERYTHEMA SOLARE IN THE NORMAL SUBJECT
WITH PYRIBENZAMINE*
ABNER KURTIN, M.D., Wiu&se BIERMAN, M.D., AND REIJBEN YONTEF, M.D.
The mechanism of action of the active portion of the ultraviolet spectrum in the produc-
tion of cutaneous erythema is still undetermined. The typical erythematous response
occuring seven hours after exposure, and increasing in intensity over a twenty-four hour
period suggests the possibility that the cell undergoes a chemical or physical change with
the subsequent slow release of some substance which is responsible for the inflammation.
There are several reports in the recent literature attesting the value of anti-histaminic
drugs in the treatment of "physical" allergies (1, 2). Inasmuch as most of the phenomena
of physical allergy are merely exaggerations of the normal response to external stimuli,
it was thought that the anti-histaminic drugs might inhibit the development of erythema
solare in a normal subject.
We performed the initial experiment by use of the technic of Pyribenzamine iontopho-
resis. An area of skin was treated with Pynibeuzamine iontophoresis (positive pole, alu-
minum electrode, 5 per cent Pyribenzamine in distilled water, milliampere per square
centimeter, five minutes). Other areas of skin were treated by similar iontophoresis of
ordinary tap water, to rule out the possibility that the iontophoresis of water was itself
responsible for any effects which might be observed. The treated area and control areas
were exposed to ultraviolet light, (hot quartz lamp), in progressively increasing dosage, (one
to ten minutes). The erythema dose on this instrument at the distance used is approx-
imately of a minute.
The typical response ranging from erythema to edema and vesiculation was seen on the
control sites after several hours, with maximum reaction occurring after twenty-four hours.
No reaction of any type was seen on the Pyribenzamine-treated area. The sites were observed
for two weeks and at no time did any erythema develop on the Pribenzamine iontophoresed
skin. Repetition of this experiment confirmed the original observation.
If our knowledge of the mode of action of Pyribenzamine is correct (antihistaminic),
this experiment indicates that erythema solare is dependent upon the action of released
histaminic substance into the tissues. The systemic symptoms following serve sunburn
also point to this possibility.
Inasmuch as massive ultraviolet exposure caused no reaction in an area where anti-
histaminic substance was present, the question is raised as to whether erythrogenic ultra-
violet radiation is directly harmful to the cell. There is some indication that cellular
damage is secondary to the local release of histaminic substance, which if inhibited, would
make the skin tolerant to any quantity of such radiation, just as it is now tolerant to rays
not in the erythrogenic wave lengths.
The inhibition of solar erythema by means of local inunction of Pyribenzamine in a
penetrating liquid vehicle is now under test. Preliminary observations indicate that this
method is effective. The practical value of such a solution in the prevention of sunburn
is evident. It is also suggested that the prostration following severe sunburn may effec-
tively be treated with Pynibenzamine.
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